Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.4M Buy
136,923
+17,329
+14% +$2.04M 0.12% 146
2025
Q4
$14.9M Buy
119,594
+13,012
+12% +$1.55M 0.14% 136
2025
Q3
$12.8M Buy
106,582
+28,143
+36% +$2.97M 0.12% 158
2025
Q2
$7.2M Buy
78,439
+47,960
+157% +$4.37M 0.08% 210
2025
Q1
$2.68M Sell
30,479
-1,517
-5% -$149K 0.04% 385
2024
Q4
$2.96M Sell
31,996
-1,042
-3% -$100K 0.05% 323
2024
Q3
$3.06M Buy
33,038
+24,167
+272% +$2.03M 0.08% 274
2024
Q2
$665K Sell
8,871
-194,178
-96% -$15.5M 0.02% 753
2024
Q1
$17.5M Buy
203,049
+198,362
+4,232% +$15.2M 0.36% 70
2023
Q4
$324K Buy
+4,687
New +$283K 0.01% 968

Other funds holding CRH

Vident Advisory's CRH Position: Q1 2026 in Review

Vident Advisory increased its CRH (CRH) stake by 14% in Q1 2026, buying an estimated $2.04M and bringing the position to 136,923 shares worth $14.4M. The position accounts for 0.12% of the portfolio, ranked #146.

Vident Advisory first reported a position in CRH in Q4 2023 and has held it in 10 quarters since. The position peaked at $17.5M in Q1 2024. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Vident Advisory held 136,923 shares of CRH worth $14.4M as of Q1 2026.
  • Vident Advisory bought 17,329 CRH shares in Q1 2026, an estimated $2.04M.
  • CRH made up 0.12% of Vident Advisory's portfolio in Q1 2026, its #146 holding.
  • Vident Advisory first reported a position in CRH in Q4 2023 and has held it in 10 quarters since.
  • Vident Advisory's CRH position peaked at $17.5M in Q1 2024.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.